Number of the records: 1  

Evaluation of serum glucose-regulated protein 78 (GRP78) as a biomarker of treatment response to bortezomib-based induction regimen in multiple myeloma: A cross-sectional pilot study

  1. TitleEvaluation of serum glucose-regulated protein 78 (GRP78) as a biomarker of treatment response to bortezomib-based induction regimen in multiple myeloma: A cross-sectional pilot study
    Author infoSuganthi Sekaran Ramachandran ... [et al.]
    Co-authors Ramachandran Suganthi Sekaran
    NoteBibliogr. odkazy. - Res. angl.
    Sign.C 720
    Source Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685. - Bratislava : AEPress , 2022 . - Vol. 69, no. 6 (2022), s. 1451-1458  : ilustr., aj fareb., obr., tab.
    MeSH Subject myelóm mnohopočetný
    bortezomib
    šaperón edoplazmatického retikula BiP : analýza
    sérum
    dreň kostná
    Subj. Headings hladina GRP78 v sére * expresia GRP78 * vyhodnotenie súboru pacientov
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.